Skip to main content

Hair Removal

0
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Lumenis
LumenisAustralia - Chatswood
2 programs
LightSheer DuetN/A1 trial
LightSheer Duet HS handpieceN/A1 trial
Active Trials
NCT01282866Completed35Est. Nov 2011
NCT01801202Completed21Est. Nov 2014
Philips
PhilipsNetherlands - Amsterdam
2 programs
Treatment with IPL deviceN/A1 trial
Treatment with IPL deviceN/A1 trial
Active Trials
NCT03921814Completed102Est. May 2022
NCT03945383Completed120Est. Jan 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PhilipsTreatment with IPL device
PhilipsTreatment with IPL device
LumenisLightSheer Duet HS handpiece
LumenisLightSheer Duet

Clinical Trials (4)

Total enrollment: 278 patients across 4 trials

NCT03945383PhilipsTreatment with IPL device

Clinical Investigation of Safety and Effectiveness of Emerald IPLdevice

Start: Apr 2019Est. completion: Jan 2022120 patients
N/ACompleted
NCT03921814PhilipsTreatment with IPL device

Sunstone IPL (Intense Pulsed Light) for Hair Reduction

Start: Apr 2019Est. completion: May 2022102 patients
N/ACompleted
NCT01801202LumenisLightSheer Duet HS handpiece

Clinical Evaluation of LightSheer Duet 805nm HS Handpiece

Start: Feb 2013Est. completion: Nov 201421 patients
N/ACompleted
NCT01282866LumenisLightSheer Duet

Hair Count Reduction Verification Study With the LightSheer Duet HS Handpiece

Start: Jun 2009Est. completion: Nov 201135 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.